World's Best Scientists 2026 revealed!
Hideo Yagita

Hideo Yagita

Award Badge
Immunology
Japan
2026
Award Badge
Medicine
Japan
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Best Scientists 165 1044 959 17 17 1069 100915
Immunology 166 62 59 4 4 1064 103086
Medicine 166 608 556 8 8 1066 103617

Hideo Yagita publications per year

The chart shows the history of publications by Hideo Yagita between 1984 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Hideo Yagita published across 42 years, from 1984 to 2025, averaging 31 papers a year. Output peaked at 216 publications in 2023. 8 of the 1,300 publications appeared in the last two years.

No. of publications
50 100 150 200
Bar chart. Horizontal axis: year, 1984 to 2025. Vertical axis: number of publications, 0 to 216. Peak 216 publications in 2023. 1984: 1 publication 1985: 0 publications 1986: 2 publications 1987: 2 publications 1988: 4 publications 1989: 9 publications 1990: 12 publications 1991: 15 publications 1992: 14 publications 1993: 13 publications 1994: 12 publications 1995: 17 publications 1996: 34 publications 1997: 32 publications 1998: 29 publications 1999: 43 publications 2000: 29 publications 2001: 39 publications 2002: 39 publications 2003: 48 publications 2004: 36 publications 2005: 44 publications 2006: 44 publications 2007: 46 publications 2008: 49 publications 2009: 44 publications 2010: 55 publications 2011: 54 publications 2012: 53 publications 2013: 57 publications 2014: 46 publications 2015: 41 publications 2016: 29 publications 2017: 19 publications 2018: 15 publications 2019: 21 publications 2020: 10 publications 2021: 12 publications 2022: 7 publications 2023: 216 publications 2024: 3 publications 2025: 5 publications
1984 2025

1,300 publications in total across all disciplines

View publications per year as a table
Hideo Yagita: publications per year, 1984 to 2025
Year Publications
1984 1
1985 0
1986 2
1987 2
1988 4
1989 9
1990 12
1991 15
1992 14
1993 13
1994 12
1995 17
1996 34
1997 32
1998 29
1999 43
2000 29
2001 39
2002 39
2003 48
2004 36
2005 44
2006 44
2007 46
2008 49
2009 44
2010 55
2011 54
2012 53
2013 57
2014 46
2015 41
2016 29
2017 19
2018 15
2019 21
2020 10
2021 12
2022 7
2023 216
2024 3
2025 5
Total 1,300
Download as CSV

Hideo Yagita publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hideo Yagita sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 807+ publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 1,064 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100 1,064
Download as CSV

Hideo Yagita D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hideo Yagita sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 157+ D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 166 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96 166
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Immunology in Japan Leader Award
  • 2026 - Research.com Medicine in Japan Leader Award
  • 2025 - Research.com Immunology in Japan Leader Award
  • 2025 - Research.com Medicine in Japan Leader Award
  • 2023 - Research.com Immunology in Japan Leader Award
  • 2023 - Research.com Medicine in Japan Leader Award
  • 2022 - Research.com Immunology in Japan Leader Award
  • 2022 - Research.com Medicine in Japan Leader Award

Overview

Hideo Yagita is affiliated with Juntendo University in Japan, where their research primarily spans the fields of immunology and microbiology, medicine, and biochemistry, genetics, and molecular biology. Their subfields of study include immunology, molecular biology, oncology, physiology, and biomedical engineering.

Their research topics focus extensively on immune cell function and interaction, immunotherapy and immune responses, cancer immunotherapy and biomarkers, CAR-T cell therapy research, T-cell and B-cell immunology, fibroblast growth factor research, and the role of immune cells in cancer.

Hideo Yagita has contributed multiple papers in notable scientific journals. Some of the recent publications include:

  • The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1 (2021, Cancer Cell)
  • PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy (2021, Nature Communications)
  • Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer (2021, Nature Communications)
  • CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer (2021, Nature Communications)
  • Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice (2020, Human Molecular Genetics)

Their frequent co-authors include:

  • Hiroyasu Nakano
  • Takashi Nishina
  • Tetuo Mikami
  • Soh Yamazaki
  • Yuichi Tsuchiya

Hideo Yagita's research has been published in a variety of scientific venues, with multiple publications in:

  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal for ImmunoTherapy of Cancer
  • iScience
  • Journal of Allergy and Clinical Immunology

Best Publications

  • Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

    Yasutoshi Agata;Akemi Kawasaki;Hiroyuki Nishimura;Yasumasa Ishida

  • PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

    Michael A. Curran;Welby Montalvo;Hideo Yagita;James P. Allison

  • Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.

    Tyler R. Simpson;Fubin Li;Welby Montalvo-Ortiz;Manuel A. Sepulveda

  • Expression of Programmed Death 1 Ligands by Murine T Cells and APC

    Tomohide Yamazaki;Hisaya Akiba;Hideyuki Iwai;Hironori Matsuda

  • Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer

    Takeo Nomi;Masayuki Sho;Takahiro Akahori;Kaoru Hamada

  • Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer

    Yuichiro Ohigashi;Masayuki Sho;Yukishige Yamada;Yoshikazu Tsurui

  • VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.

    Thibault Voron;Orianne Colussi;Elie Marcheteau;Simon Pernot

  • ATP drives lamina propria T H 17 cell differentiation

    Koji Atarashi;Junichi Nishimura;Tatsuichiro Shima;Yoshinori Umesaki

  • New aspects of natural-killer-cell surveillance and therapy of cancer

    Mark J. Smyth;Yoshihiro Hayakawa;Kazuyoshi Takeda;Hideo Yagita

  • The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.

    Mohammed Javeed I. Ansari;Alan D. Salama;Alan D. Salama;Tanuja Chitnis;Tanuja Chitnis;R. Neal Smith

  • Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

    Sergio A. Quezada;Tyler R. Simpson;Karl S. Peggs;Taha Merghoub

  • Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

    Madhav D. Sharma;Babak Baban;Phillip Chandler;De Yan Hou

  • Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells.

    Kazuyoshi Takeda;Yoshihiro Hayakawa;Mark J. Smyth;Nobuhiko Kayagaki

  • Activation of NK cell cytotoxicity.

    Mark J. Smyth;Erika Cretney;Janice M. Kelly;Jennifer A. Westwood

  • Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

    Shigeki Chiba;Muhammad Baghdadi;Hisaya Akiba;Hironori Yoshiyama

  • Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression

    Jun-Li Luo;Shin Maeda;Li-Chung Hsu;Hideo Yagita

  • Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice

    Erika Cretney;Kazuyoshi Takeda;Hideo Yagita;Moira Glaccum

  • Type I Interferons (IFNs) Regulate Tumor Necrosis Factor–related Apoptosis-inducing Ligand (TRAIL) Expression on Human T Cells: A Novel Mechanism for the Antitumor Effects of Type I IFNs

    Nobuhiko Kayagaki;Noriko Yamaguchi;Masafumi Nakayama;Hiroshi Eto

  • Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

    Alan D. Salama;Tanuja Chitnis;Tanuja Chitnis;Jaime Imitola;Jaime Imitola;Mohammed Javeed I. Ansari

  • Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1

    Hiroyasu Nakano;Masahisa Shindo;Sachiko Sakon;Shigeyuki Nishinaka

Frequent Co-Authors

Ko Okumura
Ko Okumura Juntendo University
Hisaya Akiba
Hisaya Akiba Juntendo University
Miyuki Azuma
Miyuki Azuma Tokyo Medical and Dental University
Kazuyoshi Takeda
Kazuyoshi Takeda Juntendo University
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Mohamed H. Sayegh
Mohamed H. Sayegh American University of Beirut
Hiroyasu Nakano
Hiroyasu Nakano Toho University
Nader Najafian
Nader Najafian Brigham and Women's Hospital
Tetsuji Kobata
Tetsuji Kobata Tokyo Medical and Dental University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career paths. Nursing professionals often seek specialized programs, such as an accelerated FNP program, which fast-tracks family nurse practitioner training to meet growing healthcare demands.

Transitioning between nursing specialties is also common. If you're an FNP looking to expand your skills, considering a FNP to acute care NP bridge program can provide the necessary education to shift into acute care settings.

For those new to nursing, 12-month accelerated nursing programs online for non nurses offer a streamlined route into the profession, enabling quicker entry into clinical roles supporting immunology research and patient care.

Career outlook also ties closely to salary expectations. Understanding how much do DNPs make in different states can inform decisions about where to specialize and practice, aligning educational choices with financial goals.

Best Scientists Citing Hideo Yagita

Trending Scientists

Recently Published Articles